DekaBank Deutsche Girozentrale’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $918K | Hold |
100,000
| – | – | ﹤0.01% | 883 |
|
2025
Q1 | $746K | Hold |
100,000
| – | – | ﹤0.01% | 892 |
|
2024
Q4 | $828K | Hold |
100,000
| – | – | ﹤0.01% | 905 |
|
2024
Q3 | $857K | Hold |
100,000
| – | – | ﹤0.01% | 919 |
|
2024
Q2 | $669K | Hold |
100,000
| – | – | ﹤0.01% | 955 |
|
2024
Q1 | $892K | Hold |
100,000
| – | – | ﹤0.01% | 898 |
|
2023
Q4 | $461K | Hold |
100,000
| – | – | ﹤0.01% | 1056 |
|
2023
Q3 | $313K | Hold |
100,000
| – | – | ﹤0.01% | 1120 |
|
2023
Q2 | $505K | Buy |
100,000
+75,000
| +300% | +$379K | ﹤0.01% | 1022 |
|
2023
Q1 | $137K | Buy |
+25,000
| New | +$137K | ﹤0.01% | 1230 |
|
2021
Q4 | – | Sell |
-22,900
| Closed | -$230K | – | 1460 |
|
2021
Q3 | $230K | Hold |
22,900
| – | – | ﹤0.01% | 1182 |
|
2021
Q2 | $312K | Hold |
22,900
| – | – | ﹤0.01% | 1138 |
|
2021
Q1 | $361K | Hold |
22,900
| – | – | ﹤0.01% | 1078 |
|
2020
Q4 | $454K | Buy |
+22,900
| New | +$454K | ﹤0.01% | 1041 |
|
2016
Q2 | – | Sell |
-10,000
| Closed | -$94K | – | 1027 |
|
2016
Q1 | $94K | Buy |
+10,000
| New | +$94K | ﹤0.01% | 969 |
|